XpresSpa Group Has Signed a Deal for a New XpresCheck™ COVID-19 Testing Facility at Salt Lake City International Airport
22 Dicembre 2020 - 2:30PM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it has signed a
lease amendment for an XpresCheck™ COVID-19 testing facility at
Salt Lake City International that is expected to be fully
operational by mid-January.
XpresCheck will be building a pop-up facility in
their existing XpresSpa location at Concourse A, post-security. The
Company’s pop-up building methodology enables XpresSpa to
accelerate XpresCheck’s rollout to additional airports at a lower
cost than the original modular constructed facilities. This
facility will host four separate testing rooms with an anticipated
capacity to administer over 250 tests per day. COVID-19 testing
options will include the Rapid Molecular COVID-19 Test and the
Polymerase Chain Reaction (PCR) Test.
Doug Satzman, XpresSpa CEO, stated, "We are
eager to launch XpresCheck at Salt Lake City International Airport,
where will install our pop up prototype in one of our exiting
XpresSpa locations. As the virus continues to spread, we are
prepared to address the challenge through reliable and efficient
testing that will help provide an extra layer of security and
comfort to passengers and airline employees. Our expansion of
COVID-19 testing within airports also supports our long-term goal
to become the leading brand in the rapidly emerging travel health
and wellness category.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading
global health and wellness holding company. XpresSpa Group’s core
asset, XpresSpa, is a leading airport retailer of spa services and
related health and wellness products, with 50 locations in 25
airports globally. Through its XpresTest, Inc. subsidiary, the
Company also provides COVID-19 screening and testing, rapid testing
services for other communicable diseases that include influenza,
mononucleosis and group A streptococcus, and flu vaccination
services under its XpresCheck™ brand. Current XpresCheck Wellness
Centers include JFK International Airport, Newark Liberty
International Airport, Logan International Airport, Phoenix Sky
Harbor International Airport, and Denver International Airport. To
learn more about XpresSpa Group, visit: www.XpresSpaGroup.com. To
learn more about XpresSpa, visit www.XpresSpa.com. To learn more
about XpresCheck, visit www.XpresCheck.com.
About Salt Lake City International
Airport
The Salt Lake City International Airport (SLC)
is operated and managed by the Salt Lake City Department of
Airports, a department of Salt Lake City Corporation. Prior to
the pandemic, SLC was the 23rd busiest airport in North America and
the 85th busiest in the world. More than 370 flights departed
daily to 99 nonstop destinations. SLC is undergoing a $4.1 billion
redevelopment program, the first phase of which opened in fall of
2020.
Forward-Looking Statements
This press release may contain "forward-looking"
statements within the meaning of Section 27A of the Securities Act
of 1933, and Section 21E of the Securities Exchange Act of 1934.
These include statements preceded by, followed by or that otherwise
include the words "believes," "expects," "anticipates,"
"estimates," "projects," "intends," "should," "seeks," "future,"
"continue," or the negative of such terms, or other comparable
terminology. In particular, these statements include, without
limitation, statements about our expectations relating to our new
XpresCheck™ concept, being able to expand testing to other
communicable diseases as well as administer vaccinations for the
seasonal flu, our positioning to be part of the national rollout of
various COVID-19 vaccinations as they become available, the degree
to which our public testing model assists passengers meet testing
requirements in select states and countries, our ability to
identify and gain access to the latest and best COVID-19 testing
methodologies and equipment, and our ability further expand our
initial sites and our overall ability to manage the regulatory
challenges associated with this business line.
Forward-looking statements relating to expectations about future
results or events are based upon information available to XpresSpa
Group as of today's date and are not guarantees of the future
performance of the company, and actual results may vary materially
from the results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Grossir@xpresspagroup.com(203) 682-8253
Media:Julie
FergusonJulie@jfprmedia.com(312) 385-0098
Grafico Azioni XpresSpa (NASDAQ:XSPA)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni XpresSpa (NASDAQ:XSPA)
Storico
Da Gen 2024 a Gen 2025